{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,5]],"date-time":"2026-05-05T11:52:38Z","timestamp":1777981958871,"version":"3.51.4"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2013,7,11]],"date-time":"2013-07-11T00:00:00Z","timestamp":1373500800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["World J Urol"],"published-print":{"date-parts":[[2014,4]]},"DOI":"10.1007\/s00345-013-1128-x","type":"journal-article","created":{"date-parts":[[2013,7,10]],"date-time":"2013-07-10T01:47:00Z","timestamp":1373420820000},"page":"453-459","source":"Crossref","is-referenced-by-count":25,"title":["The impact of smoking on pathologic response to neoadjuvant cisplatin-based chemotherapy in patients with muscle-invasive bladder cancer"],"prefix":"10.1007","volume":"32","author":[{"given":"Philip H.","family":"Kim","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matthew","family":"Kent","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Philip","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John P.","family":"Sfakianos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dean F.","family":"Bajorin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bernard H.","family":"Bochner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guido","family":"Dalbagni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2013,7,11]]},"reference":[{"issue":"3","key":"1128_CR1","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1200\/JCO.2001.19.3.666","volume":"19","author":"JP Stein","year":"2001","unstructured":"Stein JP, Lieskovsky G, Cote R, Groshen S, Feng AC, Boyd S, Skinner E, Bochner B, Thangathurai D, Mikhail M, Raghavan D, Skinner DG (2001) Radical cystectomy in the treatment of invasive bladder cancer: long-term results in 1,054 patients. J Clin Oncol 19(3):666\u2013675","journal-title":"J Clin Oncol"},{"issue":"9","key":"1128_CR2","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1056\/NEJMoa022148","volume":"349","author":"HB Grossman","year":"2003","unstructured":"Grossman HB, Natale RB, Tangen CM, Speights VO, Vogelzang NJ, Trump DL, deVere White RW, Sarosdy MF, Wood DP Jr, Raghavan D, Crawford ED (2003) Neoadjuvant chemotherapy plus cystectomy compared with cystectomy alone for locally advanced bladder cancer. N Engl J Med 349(9):859\u2013866. doi: 10.1056\/NEJMoa022148","journal-title":"N Engl J Med"},{"issue":"16","key":"1128_CR3","doi-asserted-by":"crossref","first-page":"2171","DOI":"10.1200\/JCO.2010.32.3139","volume":"29","author":"G Griffiths","year":"2011","unstructured":"Griffiths G, Hall R, Sylvester R, Raghavan D, Parmar MK (2011) International phase III trial assessing neoadjuvant cisplatin, methotrexate, and vinblastine chemotherapy for muscle-invasive bladder cancer: long-term results of the BA06 30894 trial. J Clin Oncol 29(16):2171\u20132177. doi: 10.1200\/JCO.2010.32.3139","journal-title":"J Clin Oncol"},{"key":"1128_CR4","doi-asserted-by":"crossref","unstructured":"Advanced Bladder Cancer Meta-analysis C (2005) Neoadjuvant chemotherapy in invasive bladder cancer: update of a systematic review and meta-analysis of individual patient data advanced bladder cancer (ABC) meta-analysis collaboration. Eur Urol 48(2):202\u2013205 (discussion 205\u2013206). doi: 10.1016\/j.eururo.2005.04.006","DOI":"10.1016\/j.eururo.2005.04.006"},{"key":"1128_CR5","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1080\/03008880802283664","volume":"218","author":"P Boffetta","year":"2008","unstructured":"Boffetta P (2008) Tobacco smoking and risk of bladder cancer. Scand J Urol Nephrol Suppl 218:45\u201354. doi: 10.1080\/03008880802283664","journal-title":"Scand J Urol Nephrol Suppl"},{"issue":"3","key":"1128_CR6","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1016\/j.urolonc.2009.06.018","volume":"28","author":"SP Lerner","year":"2010","unstructured":"Lerner SP, Grossman HB, Messing EM, Kibel AS, Stephenson A, Gee JR, O\u2019Donnell MA, Reid RD, Kamat AM, Parnes HL, House MG (2010) BCAN think tank session 3: prevention of bladder cancer. Urol Oncol 28(3):338\u2013342. doi: 10.1016\/j.urolonc.2009.06.018","journal-title":"Urol Oncol"},{"issue":"1","key":"1128_CR7","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1023\/A:1013954932343","volume":"13","author":"MP Zeegers","year":"2002","unstructured":"Zeegers MP, Goldbohm RA, van den Brandt PA (2002) A prospective study on active and environmental tobacco smoking and bladder cancer risk (The Netherlands). Cancer Causes Control 13(1):83\u201390. doi: 10.1023\/A:1013954932343","journal-title":"Cancer Causes Control"},{"key":"1128_CR8","doi-asserted-by":"crossref","unstructured":"Chen CH, Shun CT, Huang KH, Huang CY, Tsai YC, Yu HJ, Pu YS (2007) Stopping smoking might reduce tumour recurrence in nonmuscle-invasive bladder cancer. BJU Int 100 (2):281\u2013286 (discussion 286). doi: 10.1111\/j.1464-410X.2007.06873.x","DOI":"10.1111\/j.1464-410X.2007.06873.x"},{"key":"1128_CR9","author":"M Rink","year":"2012","unstructured":"Rink M, Zabor EC, Furberg H, Xylinas E, Ehdaie B, Novara G, Babjuk M, Pycha A, Lotan Y, Trinh QD, Chun FK, Lee RK, Karakiewicz PI, Fisch M, Robinson BD, Scherr DS, Shariat SF (2012) Impact of smoking and smoking cessation on outcomes in bladder cancer patients treated with radical cystectomy. Eur Urol. doi: 10.1016\/j.eururo.2012.11.039","journal-title":"Eur Urol"},{"issue":"6","key":"1128_CR10","doi-asserted-by":"crossref","first-page":"1370","DOI":"10.1002\/jcb.20741","volume":"97","author":"S Mousa","year":"2006","unstructured":"Mousa S, Mousa SA (2006) Cellular and molecular mechanisms of nicotine\u2019s pro-angiogenesis activity and its potential impact on cancer. J Cell Biochem 97(6):1370\u20131378. doi: 10.1002\/jcb.20741","journal-title":"J Cell Biochem"},{"issue":"12","key":"1128_CR11","first-page":"2093","volume":"20","author":"J Arredondo","year":"2006","unstructured":"Arredondo J, Chernyavsky AI, Jolkovsky DL, Pinkerton KE, Grando SA (2006) Receptor-mediated tobacco toxicity: cooperation of the Ras\/Raf-1\/MEK1\/ERK and JAK-2\/STAT-3 pathways downstream of alpha7 nicotinic receptor in oral keratinocytes. FASEB J (Off Publ Fed Am Soc Exp Biol) 20(12):2093\u20132101. doi: 10.1096\/fj.06-6191com","journal-title":"FASEB J (Off Publ Fed Am Soc Exp Biol)"},{"issue":"1","key":"1128_CR12","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1093\/toxsci\/kfq028","volume":"115","author":"RJ Chen","year":"2010","unstructured":"Chen RJ, Ho YS, Guo HR, Wang YJ (2010) Long-term nicotine exposure-induced chemoresistance is mediated by activation of Stat3 and downregulation of ERK1\/2 via nAChR and beta-adrenoceptors in human bladder cancer cells. Toxicol Sci 115(1):118\u2013130. doi: 10.1093\/toxsci\/kfq028","journal-title":"Toxicol Sci"},{"issue":"2","key":"1128_CR13","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1038\/onc.2012.39","volume":"32","author":"J Guo","year":"2013","unstructured":"Guo J, Kim D, Gao J, Kurtyka C, Chen H, Yu C, Wu D, Mittal A, Beg AA, Chellappan SP, Haura EB, Cheng JQ (2013) IKBKE is induced by STAT3 and tobacco carcinogen and determines chemosensitivity in non-small cell lung cancer. Oncogene 32(2):151\u2013159. doi: 10.1038\/onc.2012.39","journal-title":"Oncogene"},{"issue":"7","key":"1128_CR14","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.1093\/carcin\/bgi072","volume":"26","author":"J Tsurutani","year":"2005","unstructured":"Tsurutani J, Castillo SS, Brognard J, Granville CA, Zhang C, Gills JJ, Sayyah J, Dennis PA (2005) Tobacco components stimulate Akt-dependent proliferation and NFkappaB-dependent survival in lung cancer cells. Carcinogenesis 26(7):1182\u20131195. doi: 10.1093\/carcin\/bgi072","journal-title":"Carcinogenesis"},{"issue":"8","key":"1128_CR15","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1016\/j.ijom.2007.05.016","volume":"36","author":"J Xu","year":"2007","unstructured":"Xu J, Huang H, Pan C, Zhang B, Liu X, Zhang L (2007) Nicotine inhibits apoptosis induced by cisplatin in human oral cancer cells. Int J Oral Maxillofac Surg 36(8):739\u2013744. doi: 10.1016\/j.ijom.2007.05.016","journal-title":"Int J Oral Maxillofac Surg"},{"issue":"6","key":"1128_CR16","doi-asserted-by":"crossref","first-page":"e20806","DOI":"10.1371\/journal.pone.0020806","volume":"6","author":"X Chang","year":"2011","unstructured":"Chang X, Ravi R, Pham V, Bedi A, Chatterjee A, Sidransky D (2011) Adenylate kinase 3 sensitizes cells to cigarette smoke condensate vapor induced cisplatin resistance. PLoS ONE 6(6):e20806. doi: 10.1371\/journal.pone.0020806","journal-title":"PLoS ONE"},{"key":"1128_CR17","volume-title":"AJCC cancer staging manual","author":"SB Edge","year":"2010","unstructured":"Edge SB (2010) AJCC cancer staging manual, 7th edn. Springer, New York","edition":"7"},{"issue":"11","key":"1128_CR18","doi-asserted-by":"crossref","first-page":"2337","DOI":"10.1002\/(SICI)1097-0142(19991201)86:11<2337::AID-CNCR23>3.0.CO;2-6","volume":"86","author":"N Fleshner","year":"1999","unstructured":"Fleshner N, Garland J, Moadel A, Herr H, Ostroff J, Trambert R, O\u2019Sullivan M, Russo P (1999) Influence of smoking status on the disease-related outcomes of patients with tobacco-associated superficial transitional cell carcinoma of the bladder. Cancer 86(11):2337\u20132345","journal-title":"Cancer"},{"key":"1128_CR19","author":"B Ehdaie","year":"2012","unstructured":"Ehdaie B, Furberg H, Zabor EC, Ostroff JS, Shariat SF, Bochner BH, Coleman JA, Dalbagni G (2012) Impact of smoking status at diagnosis on disease recurrence and death in upper tract urothelial carcinoma. BJU Int. doi: 10.1111\/j.1464-410X.2012.11260.x","journal-title":"BJU Int"},{"issue":"18","key":"1128_CR20","doi-asserted-by":"crossref","first-page":"4104","DOI":"10.1002\/cncr.24466","volume":"115","author":"G Sonpavde","year":"2009","unstructured":"Sonpavde G, Goldman BH, Speights VO, Lerner SP, Wood DP, Vogelzang NJ, Trump DL, Natale RB, Grossman HB, Crawford ED (2009) Quality of pathologic response and surgery correlate with survival for patients with completely resected bladder cancer after neoadjuvant chemotherapy. Cancer 115(18):4104\u20134109. doi: 10.1002\/cncr.24466","journal-title":"Cancer"},{"issue":"3","key":"1128_CR21","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1016\/j.eururo.2007.03.086","volume":"52","author":"W Kassouf","year":"2007","unstructured":"Kassouf W, Spiess PE, Brown GA, Munsell MF, Grossman HB, Siefker-Radtke A, Dinney CP, Kamat AM (2007) P0 stage at radical cystectomy for bladder cancer is associated with improved outcome independent of traditional clinical risk factors. Eur Urol 52(3):769\u2013774. doi: 10.1016\/j.eururo.2007.03.086","journal-title":"Eur Urol"},{"issue":"16","key":"1128_CR22","doi-asserted-by":"crossref","first-page":"5490","DOI":"10.1158\/1078-0432.CCR-11-0724","volume":"17","author":"RS Huang","year":"2011","unstructured":"Huang RS, Johnatty SE, Gamazon ER, Im HK, Ziliak D, Duan S, Zhang W, Kistner EO, Chen P, Beesley J, Mi S, O\u2019Donnell PH, Fraiman YS, Das S, Cox NJ, Lu Y, Macgregor S, Goode EL, Vierkant RA, Fridley BL, Hogdall E, Kjaer SK, Jensen A, Moysich KB, Grasela M, Odunsi K, Brown R, Paul J, Lambrechts D, Despierre E, Vergote I, Gross J, Karlan BY, Defazio A, Chenevix-Trench G, Dolan ME (2011) Platinum sensitivity-related germline polymorphism discovered via a cell-based approach and analysis of its association with outcome in ovarian cancer patients. Clin Cancer Res (Off J Am Assoc Cancer Res) 17(16):5490\u20135500. doi: 10.1158\/1078-0432.CCR-11-0724","journal-title":"Clin Cancer Res (Off J Am Assoc Cancer Res)"},{"issue":"17","key":"1128_CR23","doi-asserted-by":"crossref","first-page":"5562","DOI":"10.1158\/1078-0432.CCR-11-0790","volume":"17","author":"L Friboulet","year":"2011","unstructured":"Friboulet L, Barrios-Gonzales D, Commo F, Olaussen KA, Vagner S, Adam J, Goubar A, Dorvault N, Lazar V, Job B, Besse B, Validire P, Girard P, Lacroix L, Hasmats J, Dufour F, Andre F, Soria JC (2011) Molecular characteristics of ERCC1-negative versus ERCC1-positive tumors in resected NSCLC. Clin Cancer Res (Off J Am Assoc Cancer Res) 17(17):5562\u20135572. doi: 10.1158\/1078-0432.CCR-11-0790","journal-title":"Clin Cancer Res (Off J Am Assoc Cancer Res)"},{"issue":"7","key":"1128_CR24","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1093\/aje\/kwp215","volume":"170","author":"NL Benowitz","year":"2009","unstructured":"Benowitz NL, Schultz KE, Haller CA, Wu AH, Dains KM, Jacob P 3rd (2009) Prevalence of smoking assessed biochemically in an urban public hospital: a rationale for routine cotinine screening. Am J Epidemiol 170(7):885\u2013891. doi: 10.1093\/aje\/kwp215","journal-title":"Am J Epidemiol"},{"issue":"4","key":"1128_CR25","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1016\/j.eururo.2011.07.010","volume":"60","author":"RJ Lammers","year":"2011","unstructured":"Lammers RJ, Witjes WP, Hendricksen K, Caris CT, Janzing-Pastors MH, Witjes JA (2011) Smoking status is a risk factor for recurrence after transurethral resection of non-muscle-invasive bladder cancer. Eur Urol 60(4):713\u2013720. doi: 10.1016\/j.eururo.2011.07.010","journal-title":"Eur Urol"},{"issue":"10","key":"1128_CR26","doi-asserted-by":"crossref","first-page":"2287","DOI":"10.1158\/1055-9965.EPI-05-0224","volume":"14","author":"ER Gritz","year":"2005","unstructured":"Gritz ER, Dresler C, Sarna L (2005) Smoking, the missing drug interaction in clinical trials: ignoring the obvious. Cancer Epidemiol Biomarkers Prev 14(10):2287\u20132293. doi: 10.1158\/1055-9965.EPI-05-0224","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"5","key":"1128_CR27","doi-asserted-by":"crossref","first-page":"1901","DOI":"10.1016\/j.juro.2010.06.140","volume":"184","author":"MA Bjurlin","year":"2010","unstructured":"Bjurlin MA, Goble SM, Hollowell CM (2010) Smoking cessation assistance for patients with bladder cancer: a national survey of American urologists. J Urol 184(5):1901\u20131906. doi: 10.1016\/j.juro.2010.06.140","journal-title":"J Urol"}],"container-title":["World Journal of Urology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00345-013-1128-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00345-013-1128-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00345-013-1128-x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,7,17]],"date-time":"2019-07-17T18:19:35Z","timestamp":1563387575000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00345-013-1128-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,7,11]]},"references-count":27,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2014,4]]}},"alternative-id":["1128"],"URL":"https:\/\/doi.org\/10.1007\/s00345-013-1128-x","relation":{},"ISSN":["0724-4983","1433-8726"],"issn-type":[{"value":"0724-4983","type":"print"},{"value":"1433-8726","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,7,11]]}}}